Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.

Epidermal growth factor (EGF) may be important in regulating the growth of some breast cancer cells in vivo because of its mitogenic action on some breast cancer cell lines in vitro. Epidermal growth factor receptors (EGF-R) were measured in a series of breast tumors to determine what percentage of breast tumors express EGF-R and whether EGF-R was independent of expression of estrogen receptor and progestin receptor. Specific binding of 125I-EGF to membranes from pooled homogenates of breast tumors reached equilibrium after 45 min at 25 degrees and remained constant. Scatchard analysis of 125I-EGF binding indicated a single class of receptors with an apparent Kd of 2 nM and a binding capacity of 28 fmol/mg of membrane protein, and the binding of 125I-EGF was not effectively competed for by insulin, fibroblast growth factor, growth hormone, or prolactin. Specific binding of 125I-EGF of 1 fmol or greater/mg of membrane protein and 15% or greater specific binding was detected in 48% of 137 unselected primary and metastatic breast tumors. The frequency distribution of EGF binding values was unimodal, with a progressive decrease in the proportion of patients with high EGF binding values. The values of EGF binding ranged from 1 to 121 fmol/mg of protein, with an arithmetic mean of 8.4 fmol/mg of protein and a geometric mean of 3.2 fmol/mg of protein. Forty-two % of 24 metastatic breast tumors were positive for EGF binding, with an arithmetic mean of 6.3 fmol/mg of protein and a geometric mean of 4.1 fmol/mg of protein. The magnitude of EGF binding in individual tumors was independent of either estrogen receptor or progestin receptor levels, although the highest quantities of EGF binding were expressed by tumors lacking steroid receptors. Approximately 20% of the tumors in the study were EGF-R-positive and ER-negative, suggesting that the growth of these tumors may be regulated predominantly by a peptide hormone (EGF) rather than a steroid hormone (estrogen). EGF binding did not correlate significantly with age of the patients. Correlation analysis between EGF binding and the percentage of malignant and nonmalignant cell types present in sections of tumor adjacent to the area assayed for EGF binding indicated that the percentage of malignant cells is an important factor in determining the amount of EGF binding in tumor homogenates. The recent discovery of transforming growth factors which interact with the EGF-receptor system suggests additional roles for EGF receptors in breast cancer.

[1]  G. Schultz,et al.  Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. , 1984, Cancer research.

[2]  M. Sporn,et al.  Transforming growth factors from neoplastic and nonneoplastic tissues. , 1983, Federation proceedings.

[3]  D. Twardzik,et al.  High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer. , 1983, Cancer research.

[4]  Y. Imai,et al.  Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture. , 1982, Cancer research.

[5]  J. Massagué,et al.  Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[6]  B. Hamilton,et al.  Receptor binding and processing of epidermal growth factor by human breast cancer cells. , 1982, The Journal of clinical endocrinology and metabolism.

[7]  P. Comens,et al.  Direct linkage of 125I-EGF to cell surface receptors. A useful artifact of chloramine-T treatment. , 1982, The Journal of biological chemistry.

[8]  G. Markus,et al.  Plasminogen activator activity and composition in human breast cancer. , 1982, Cancer research.

[9]  J. Minna,et al.  Expression of epidermal and nerve growth factor receptors and soft agar growth factor production by human lung cancer cells. , 1981, Cancer research.

[10]  J. Wittliff,et al.  Methods of steroid receptor analyses and their quality control in the clinical laboratory. , 1981, Progress in clinical and biological research.

[11]  M. Lippman,et al.  Quantitative estrogen receptor analyses: The response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease‐free interval , 1980, Cancer.

[12]  M. Hollenberg,et al.  Characterization of the receptor for epidermal growth factor-urogastrone in human placenta membranes. , 1980, The Journal of biological chemistry.

[13]  G. Todaro,et al.  Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Osborne,et al.  Epidermal growth factor stimulation of human breast cancer cells in culture. , 1980, Cancer research.

[15]  L. Miller,et al.  Estrogen receptor cleavage and plasminogen activation by enzymes in human breast tumor cytosol. , 1980, Endocrinology.

[16]  A. Howell,et al.  Effect of prolactin on lactalbumin production by normal and malignant human breast tissue in organ culture. , 1980, Cancer Research.

[17]  R. Shiu Prolactin receptors in human breast cancer cells in long-term tissue culture. , 1979, Cancer Research.

[18]  G. Hortobagyi,et al.  Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. , 1979, Cancer research.

[19]  W. McGuire Steroid receptors in human breast cancer. , 1978, Cancer research.

[20]  E. J. Gregory,et al.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. , 1977, Cancer research.

[21]  S. Cohen,et al.  Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization. , 1972, The Journal of biological chemistry.

[22]  R. Ceriani,et al.  Hormone requirement for growth and differentiation of the human mammary gland in organ culture. , 1972, Cancer research.

[23]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.